XIAMEN LP PHARM CO FDA Approval ANDA 213985

ANDA 213985

XIAMEN LP PHARM CO

FDA Drug Application

Application #213985

Application Sponsors

ANDA 213985XIAMEN LP PHARM CO

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL7MG0MEMANTINE HYDROCHLORIDEMEMANTINE HYDROCHLORIDE
002CAPSULE, EXTENDED RELEASE;ORAL14MG0MEMANTINE HYDROCHLORIDEMEMANTINE HYDROCHLORIDE
003CAPSULE, EXTENDED RELEASE;ORAL28MG0MEMANTINE HYDROCHLORIDEMEMANTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-10-11STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

XIAMEN LP PHARM CO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213985
            [companyName] => XIAMEN LP PHARM CO
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"7MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"14MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"28MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/11\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-11
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.